13F HOLDINGS REPORT
Ghost Tree Capital, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001420506-24-000902
Total Value
$361.3M
Positions
72
Other Managers
0
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 250,000 | $23.7M | 6.57% |
| 2 | AXSOME THERAPEUTICS INC | AXSM | 210,000 | $16.8M | 4.64% |
| 3 | SAREPTA THERAPEUTICS INC | SRPT | 125,000 | $16.2M | 4.48% |
| 4 | BIOHAVEN LTD | BHVN | 285,000 | $15.6M | 4.31% |
| 5 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 300,000 | $15.1M | 4.17% |
| 6 | ROIVANT SCIENCES LTD | ROIV | 1,300,000 | $13.7M | 3.79% |
| 7 | TG THERAPEUTICS INC | TGTX | 825,000 | $12.5M | 3.47% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 625,000 | $10.9M | 3.03% |
| 9 | TARSUS PHARMACEUTICALS INC | TARS | 300,000 | $10.9M | 3.02% |
| 10 | CRINETICS PHARMACEUTICALS IN | CRNX | 200,000 | $9.4M | 2.59% |
| 11 | ALNYLAM PHARMACEUTICALS INC | ALNY | 60,000 | $9.0M | 2.48% |
| 12 | SOLENO THERAPEUTICS INC | SLNO | 200,000 | $8.6M | 2.37% |
| 13 | SAVARA INC | SVRA | 1,600,000 | $8.0M | 2.21% |
| 14 | APELLIS PHARMACEUTICALS INC | APLS | 130,000 | $7.6M | 2.12% |
| 15 | PERSPECTIVE THERAPEUTICS INC | CATX | 6,000,000 | $7.1M | 1.98% |
| 16 | BLUEPRINT MEDICINES CORP | 09627Y109 | 72,761 | $6.9M | 1.91% |
| 17 | AEROVATE THERAPEUTICS INC | 008064107 | 225,000 | $6.7M | 1.84% |
| 18 | VIKING THERAPEUTICS INC | VKTX | 80,000 | $6.6M | 1.82% |
| 19 | VAXCYTE INC | PCVX | 95,000 | $6.5M | 1.80% |
| 20 | CABALETTA BIO INC | CABA | 375,000 | $6.4M | 1.77% |
| 21 | VIKING THERAPEUTICS INC | VKTX | 73,002 | $6.0M | 1.66% |
| 22 | RHYTHM PHARMACEUTICALS INC | RYTM | 125,000 | $5.4M | 1.50% |
| 23 | BRIDGEBIO PHARMA INC | BBIO | 175,000 | $5.4M | 1.50% |
| 24 | REPLIMUNE GROUP INC | REPL | 650,000 | $5.3M | 1.47% |
| 25 | CYTOKINETICS INC | CYTK | 75,000 | $5.3M | 1.46% |
| 26 | PHATHOM PHARMACEUTICALS INC | PHAT | 485,000 | $5.2M | 1.43% |
| 27 | IMMUNOVANT INC | IMVT | 150,000 | $4.8M | 1.34% |
| 28 | ACADIA PHARMACEUTICALS INC | ACAD | 225,000 | $4.2M | 1.15% |
| 29 | INSMED INC | INSM | 150,000 | $4.1M | 1.13% |
| 30 | TENAYA THERAPEUTICS INC | TNYA | 775,000 | $4.1M | 1.12% |
| 31 | IMMUNOVANT INC | IMVT | 125,000 | $4.0M | 1.12% |
| 32 | SPYRE THERAPEUTICS INC | SYRE | 100,000 | $3.8M | 1.05% |
| 33 | ACADIA PHARMACEUTICALS INC | ACAD | 200,000 | $3.7M | 1.02% |
| 34 | SYNDAX PHARMACEUTICALS INC | SNDX | 150,000 | $3.6M | 0.99% |
| 35 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 50,000 | $3.5M | 0.96% |
| 36 | ENGENE HOLDINGS INC | ENGNW | 200,000 | $3.4M | 0.94% |
| 37 | CG ONCOLOGY INC | CGON | 75,000 | $3.3M | 0.91% |
| 38 | STRUCTURE THERAPEUTICS INC | GPCR | 75,000 | $3.2M | 0.89% |
| 39 | HELIX ACQUISITION CORP II | HLXC | 300,000 | $3.1M | 0.86% |
| 40 | COGENT BIOSCIENCES INC | COGT | 450,000 | $3.0M | 0.84% |
| 41 | AQUESTIVE THERAPEUTICS INC | AQST | 702,941 | $3.0M | 0.83% |
| 42 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 176,513 | $2.8M | 0.77% |
| 43 | TAYSHA GENE THERAPIES INC | TSHA | 950,000 | $2.7M | 0.75% |
| 44 | RAPT THERAPEUTICS INC | 75382E109 | 300,000 | $2.7M | 0.75% |
| 45 | GERON CORP | GERN | 800,000 | $2.6M | 0.73% |
| 46 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 285,000 | $2.6M | 0.71% |
| 47 | ALTIMMUNE INC | ALT | 250,000 | $2.5M | 0.70% |
| 48 | REGENXBIO INC | RGNX | 120,000 | $2.5M | 0.70% |
| 49 | KRYSTAL BIOTECH INC | KRYS | 14,000 | $2.5M | 0.69% |
| 50 | KALVISTA PHARMACEUTICALS INC | KALV | 200,000 | $2.4M | 0.66% |
| 51 | NATERA INC | NTRA | 25,000 | $2.3M | 0.63% |
| 52 | OLEMA PHARMACEUTICALS INC | OLMA | 200,000 | $2.3M | 0.63% |
| 53 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 56,941 | $2.2M | 0.62% |
| 54 | REVANCE THERAPEUTICS INC | 761330109 | 450,000 | $2.2M | 0.61% |
| 55 | PROTAGONIST THERAPEUTICS INC | PTGX | 75,000 | $2.2M | 0.60% |
| 56 | EYEPOINT PHARMACEUTICALS INC | EYPT | 90,000 | $1.9M | 0.51% |
| 57 | MADRIGAL PHARMACEUTICALS INC | MDGL | 6,500 | $1.7M | 0.48% |
| 58 | ARVINAS INC | ARVN | 40,000 | $1.7M | 0.46% |
| 59 | ASTRIA THERAPEUTICS INC | 04635X102 | 115,000 | $1.6M | 0.45% |
| 60 | LARIMAR THERAPEUTICS INC | LRMR | 210,603 | $1.6M | 0.44% |
| 61 | CYTOKINETICS INC | CYTK | 20,000 | $1.4M | 0.39% |
| 62 | CYTOMX THERAPEUTICS INC | CTMX | 600,000 | $1.3M | 0.36% |
| 63 | ELEVATION ONCOLOGY INC | 28623U101 | 250,000 | $1.3M | 0.35% |
| 64 | NEUROGENE INC | NGNE | 25,000 | $1.3M | 0.35% |
| 65 | SAGIMET BIOSCIENCES INC | SGMT | 225,000 | $1.2M | 0.34% |
| 66 | ATYR PHARMA INC | ATYR | 600,000 | $1.2M | 0.32% |
| 67 | PMV PHARMACEUTICALS INC | PMVP | 675,000 | $1.1M | 0.32% |
| 68 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 35,000 | $1.0M | 0.28% |
| 69 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 20,000 | $933,800 | 0.26% |
| 70 | UNIQURE NV | QURE | 165,000 | $858,000 | 0.24% |
| 71 | AN2 THERAPEUTICS INC | ANTX | 219,331 | $712,826 | 0.20% |
| 72 | INTELLIA THERAPEUTICS INC | NTLA | 25,000 | $687,750 | 0.19% |